2011
DOI: 10.1016/j.clon.2010.10.008
|View full text |Cite
|
Sign up to set email alerts
|

Management of Patients with Head and Neck Tumours Presenting at Diagnosis with a Synchronous Second Cancer at Another Anatomic Site

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
18
0
3

Year Published

2013
2013
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(21 citation statements)
references
References 16 publications
0
18
0
3
Order By: Relevance
“…This was also noted by Wang, Lee, et al This discrepancy could indicate that without an active screening program, esophageal‐SPTs are underdiagnosed in patients with HNSCC . Multiple studies state that the occurrence of esophageal‐SPTs negatively influences patient survival, especially in patients with advanced esophageal‐SPTs . Some researchers even claim that SPTs are the leading cause of treatment failure and death in patients with HNSCC …”
Section: Discussionmentioning
confidence: 81%
“…This was also noted by Wang, Lee, et al This discrepancy could indicate that without an active screening program, esophageal‐SPTs are underdiagnosed in patients with HNSCC . Multiple studies state that the occurrence of esophageal‐SPTs negatively influences patient survival, especially in patients with advanced esophageal‐SPTs . Some researchers even claim that SPTs are the leading cause of treatment failure and death in patients with HNSCC …”
Section: Discussionmentioning
confidence: 81%
“…Graff et al have shown that a synchronous primary with high staged index tumor in the head and neck region and with esophageal involvement carries a poor prognosis, so identification of the presence or occurrence of synchronous primary with a low stage tumor and without esophageal involvement could most benefit from an aggressive form of treatment. [28] This can be achieved by doing UGIE to rule out the esophageal involvement. In our analysis, majority of synchronous cancers occurred with the higher staged (Stage III and Stage IV) index tumor, which is 64% of the total and in almost 65% of esophageal synchronous cancer there were associated Stage III and Stage IV index tumor.…”
Section: Discussionmentioning
confidence: 99%
“…Although these patients belong to a complex group, if their clinical general conditions allow it, an aggressive loco-regional treatment would be indicated [15].…”
Section: Discussionmentioning
confidence: 99%